Skip to main content
Have a personal or library account? Click to login
Exposure of Human Endothelial Progenitors to Sevoflurane Improves Their Survival Abilities Cover

Exposure of Human Endothelial Progenitors to Sevoflurane Improves Their Survival Abilities

Revista Romana de Medicina de Laborator
Volume 24 (2016): Issue 2 (June 2016)
By: ,  ,  ,  ,   and    
Open Access
|Jun 2016
References

References

  1. 1. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A. 2001;98(18):10344-9. DOI: 10.1073/pnas.181177898.
    Open DOISearch in Google Scholar
  2. 2. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki KI, Eguchi H, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest. 2000;105(11):1527-36. DOI: 10.1172/JCI8296.
    Open DOISearch in Google Scholar
  3. 3. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A. 2000;97(7):3422-7. DOI: 10.1073/pnas.97.7.3422.
    Open DOISearch in Google Scholar
  4. 4. Losordo DW, Henry TD, Davidson C, Sup Lee J, Costa MA, Bass T, et al. Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina / Novelty and Significance. Circ Res. 2011;109(4):428-36. DOI: 10.1161/CIRCRESAHA.111.245993.
    Open DOISearch in Google Scholar
  5. 5. Doyle B, Sorajja P, Hynes B, Kumar AHS, Araoz P a, Stalboerger PG, et al. Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1. Stem Cells Dev. 2008;17(5):941-51. DOI: 10.1089/scd.2007.0214.
    Open DOISearch in Google Scholar
  6. 6. Jujo K, Ii M, Losordo DW. Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol. 2008;45(4):530-44. DOI: 10.1016/j. yjmcc.2008.08.003.
    Search in Google Scholar
  7. 7. Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J. 2006;27(9):1114-22. DOI: 10.1093/eurheartj/ehi818.
    Open DOISearch in Google Scholar
  8. 8. Herrmann JL, Abarbanell AM, Weil BR, Manukyan MC, Poynter J a, Brewster BJ, et al. Optimizing stem cell function for the treatment of ischemic heart disease. J Surg Res. 2011;166(1):138-45. DOI: 10.1016/j.jss.2010.05.057.
    Open DOISearch in Google Scholar
  9. 9. Landoni G, Bignami E, Oliviero F, Zangrillo A. Halogenated anaesthetics and cardiac protection in cardiac and non-cardiac anaesthesia. Ann Card Anaesth. 2009;12(1):4-9. DOI: 10.4103/0971-9784.45006
    Open DOISearch in Google Scholar
  10. 10. Frässdorf J, De Hert S, Schlack W. Anaesthesia and myocardial ischaemia/reperfusion injury. Br J Anaesth. 2009;103(1):89-98. DOI: 10.1093/bja/aep141.
    Open DOISearch in Google Scholar
  11. 11. Stadnicka A, Marinovic J, Ljubkovic M, Bienengraeber MW, Bosnjak ZJ. Volatile anesthetic-induced cardiac preconditioning. J Anesth. 2007;21(2):212-9. DOI: 10.1007/s00540-006-0486-6.
    Open DOISearch in Google Scholar
  12. 12. Popescu M, Munteanu A, Isvoranu G, Suciu L, Pavel B, Marinescu B, et al. Dynamics of endothelial progenitor cells following sevoflurane preconditioning. Roum Arch Microbiol Immunol. 2011 Jul-Sep;70(3):109-13.
    Search in Google Scholar
  13. 13. Lucchinetti E, Zeisberger SM, Baruscotti I, Wacker J, Feng J, Zaugg K, et al. Stem cell-like human endothelial progenitors show enhanced colony-forming capacity after brief sevoflurane exposure: preconditioning of angiogenic cells by volatile anesthetics. Anesth Analg. 2009;109(4):1117-26. DOI: 10.1213/ ANE.0b013e3181b5a277.
    Open DOISearch in Google Scholar
  14. 14. Sun X, Fang B, Zhao X, Zhang G, Ma H. Preconditioning of mesenchymal stem cells by sevoflurane to improve their therapeutic potential. PLoS One. 2014;9(3):e90667. DOI: 10.1371/journal. pone.0090667.
    Search in Google Scholar
  15. 15. Vasa M, Fichtlscherer S, Aicher a, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89(1):E1-7. DOI: 10.1161/hh1301.093953.
    Open DOISearch in Google Scholar
  16. 16. Hibbert B, Ma X, Pourdjabbar A, Simard T, Rayner K, Sun J, et al. Pre-procedural atorvastatin mobilizes endothelial progenitor cells: clues to the salutary effects of statins on healing of stented human arteries. PLoS One. 2011;6(1):e16413. DOI: 10.1371/journal. pone.0016413.
    Search in Google Scholar
  17. 17. Zentilin L, Tafuro S, Zacchigna S, Arsic N, Pattarini L, Sinigaglia M, et al. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood. 2006;107(9):3546-54. DOI: 10.1182/ blood-2005-08-3215.
    Open DOISearch in Google Scholar
  18. 18. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Yung S, et al. VEGF-induced adult neovascularization: Recruitment, retention, and role of accessory cells. Cell. 2006;124(1):175-89. DOI: 10.1016/j. cell.2005.10.036.
    Search in Google Scholar
  19. 19. Thum T, Tsikas D, Stein S, Schultheiss M, Eigenthaler M, Anker SD, et al. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol. 2005;46(9):1693-701. DOI: 10.1016/j.jacc.2005.04.066.
    Open DOISearch in Google Scholar
  20. 20. Hibbert B, Ma X, Pourdjabbar A, Holm E, Rayner K, Chen Y-X, et al. Inhibition of endothelial progenitor cell glycogen synthase kinase-3beta results in attenuated neointima formation and enhanced re-endothelialization after arterial injury. Cardiovasc Res. 2009;83(1):16-23. DOI: 10.1093/cvr/cvp156.
    Open DOISearch in Google Scholar
  21. 21. Hirschi KK, Ingram D a., Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2008;28(9):1584-95. DOI: 10.1161/ATVBAHA.107.155960.
    Open DOISearch in Google Scholar
  22. 22. Bedirli N, Bagriacik EU, Emmez H, Yilmaz G, Unal Y, Ozkose Z. Sevoflurane and Isoflurane Preconditioning Provides Neuroprotection by Inhibition of Apoptosis-related mRNA Expression in a Rat Model of Focal Cerebral Ischemia. J Neurosurg Anesthesiol. 2012;24(4):336-44. DOI: 10.1097/ ANA.0b013e318266791e.
    Open DOISearch in Google Scholar
  23. 23. Codaccioni J-L, Velly LJ, Moubarik C, Bruder NJ, Pisano PS, Guillet B a. Sevoflurane preconditioning against focal cerebral ischemia: inhibition of apoptosis in the face of transient improvement of neurological outcome. Anesthesiology. 2009;110(6):1271-8. DOI: 10.1097/ALN.0b013e3181a1fe68.
    Open DOISearch in Google Scholar
  24. 24. Liu Y, Shi L, Liu C, Zhu G, Li H, Zhao H, et al. Effect of combination therapy of propofol and sevoflurane on MAP2K3 level and myocardial apoptosis induced by ischemia-reperfusion in rats. Int J Clin Exp Med. 2015 Apr 15;8(4):6427-35.
    Search in Google Scholar
  25. 25. Zhang J, Wang C, Yu S, Luo Z, Chen Y, Liu Q, et al. Sevoflurane Postconditioning Protects Rat Hearts against Ischemia-Reperfusion Injury via the Activation of PI3K/AKT/mTOR Signaling. Sci Rep. 2014;4:7317. DOI: 10.1038/srep07317.
    Open DOISearch in Google Scholar
  26. 26. Zhang YL, Yao YT, Fang NX, Zhou CH, Gong JS, Li LH. Restoration of autophagic flux in myocardial tissues is required for cardioprotection of sevoflurane postconditioning in rats. Acta Pharmacol Sin. 2014 Jun;35(6):758-69. DOI: 10.1038/aps.2014.20.
    Open DOISearch in Google Scholar
  27. 27. Theus MH, Wei L, Cui L, Francis K, Hu X, Keogh C, et al. In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Experimental Neurology. 2008. p. 656-70. DOI: 10.1016/j.expneurol.2007.12.020.
    Open DOISearch in Google Scholar
  28. 28. Hu X, Yu SP, Fraser JL, Lu Z, Ogle ME, Wang J-A, et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg [Internet]. 2008;135(4):799-808. DOI: 10.1016/j.jtcvs.2007.07.071.
    Open DOISearch in Google Scholar
  29. 29. Akita T, Murohara T, Ikeda H, Sasaki K-I, Shimada T, Egami K, et al. Hypoxic preconditioning augments efficacy of human endothelial progenitor cells for therapeutic neovascularization. Lab Invest. 2003;83(1):65-73. DOI: 10.1097/01.LAB.0000050761.67879.E4.
    Open DOISearch in Google Scholar
  30. 30. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002;106(22):2781-6. DOI: 10.1161/01.CIR.0000039526.42991.93.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.1515/rrlm-2016-0022 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624 (formerly 2284-5623)
Journal RSS Feed
Language: English
Page range: 177 - 186
Submitted on: Dec 23, 2015
Accepted on: May 3, 2016
Published on: Jun 28, 2016
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Keywords:
priming,
sevoflurane,
progenitor cells,
apoptosis,
proliferation
Related subjects:
Life sciences,
Molecular biology

© 2016 Adelina Munteanu, Marilena Gilca, Gheorghita Isvoranu, Mihaela Surcel, Laura Ceafalan, Gina Manda, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 24 (2016): Issue 2 (June 2016)
Previous article
Next article